Diabetes Core Update cover image

Diabetes Core Update – March 2023

Diabetes Core Update

00:00

Diabetes Care - Is This a Safety Measure?

Golimomab is a monoclonal antibody that goes against TNF-alpha, tumor necrosis factor. It gets in the way of lymphocyte activation and destruction of beta cells. The Tiger trial showed both during the time that this was given as well as for a year afterwards, this concept worked. Our next article is on an important and disturbing topic, which is youth onset diabetes.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app